Cargando…
Long‐term Phase 1/2 intraspinal stem cell transplantation outcomes in ALS
OBJECTIVE: Intraspinal human spinal cord‐derived neural stem cell (HSSC) transplantation is a potential therapy for amyotrophic lateral sclerosis (ALS); however, previous trials lack controls. This post hoc analysis compared ambulatory limb‐onset ALS participants in Phase 1 and 2 (Ph1/2) open‐label...
Autores principales: | Goutman, Stephen A., Brown, Morton B., Glass, Jonathan D., Boulis, Nicholas M., Johe, Karl, Hazel, Tom, Cudkowicz, Merit, Atassi, Nazem, Borges, Lawrence, Patil, Parag G., Sakowski, Stacey A., Feldman, Eva L. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5989736/ https://www.ncbi.nlm.nih.gov/pubmed/29928656 http://dx.doi.org/10.1002/acn3.567 |
Ejemplares similares
-
Intraspinal Neural Stem Cell Transplantation in Amyotrophic Lateral Sclerosis: Phase 1 Trial Outcomes
por: Feldman, Eva L, et al.
Publicado: (2014) -
Randomized, double-blind, placebo-controlled trial of arimoclomol in rapidly progressive SOD1 ALS
por: Benatar, Michael, et al.
Publicado: (2018) -
Analysis of graft survival in a trial of stem cell transplant in ALS
por: Tadesse, Tezeta, et al.
Publicado: (2014) -
Human Cortical Neural Stem Cells Expressing Insulin-Like Growth Factor-I: A Novel Cellular Therapy for Alzheimer’s Disease
por: McGinley, Lisa M., et al.
Publicado: (2016) -
Intraspinal Cocainisation
Publicado: (1904)